Ch. 38 - Chapter 38 Hormone Replacement Therapy and...

Chapter 38. Hormone Replacement Therapy and Osteoporosis
Multiple Choice
Identify the choice that best completes the statement or answers the question.
____ 1.
The goals of therapy when prescribing hormone replacement therapy (HRT) include reducing:
1. Cardiovascular risk
2. Risk of stroke or other thromboembolic event
3. Breast cancer
4.
Vasomotor symptoms
____ 2.
The optimal maximum time frame for HRT or estrogen replacement therapy (ERT) is:
1. 2 years
2.
5 years
3. 10 years
4. 15 years
____ 3.
Dosage changes of conjugated equine estrogen (Premarin) are made at _________ intervals.
1. 1 to 2 week
2. 2 to 4 week
3. 6 to 8 week
4. 12 week
____ 4.
The advantage of vaginal estrogen preparations in the treatment of vulvovaginal atrophy and dryness
is:
1. Ability to deliver higher doses of estrogen in a non-oral form
2. The vaginal cream formula provides moisture to the vaginal area
3. Relief of symptoms without increasing cardiovascular risk
4. All of the above
____ 5.
Women with an intact uterus should be treated with both estrogen and progestin due to:
1. Increased risk for endometrial cancer if estrogen alone is used
2. Combination therapy provides the best relief of menopausal vasomotor symptoms
3. Reduced risk for colon cancer with combined therapy
4. Lower risk of developing blood clots with combined therapy
____ 6.
Ongoing monitoring for women on ERT includes:
1. Lipid levels, repeated annually if abnormal
2. Annual health history and review of risk profile
3. Annual mammogram
4.